ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/6-D-ala-gonadorelin
C56H77N17O13
1196.3 g/mol
APIDanger

6-D-Ala-gonadorelin

CAS51230-19-4
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

6-D-Ala-gonadorelin is a synthetic peptide compound used as an active pharmaceutical ingredient. It is a decapeptide analog of gonadorelin, featuring a D-alanine substitution at position 6, which modifies its biological activity.

Pharmaceutical raw material for peptide-based drug manufacturingResearch compound for gonadorelin analog studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing 6-D-Ala-gonadorelin?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.97

Triptorelin

CAS57773-63-4

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.97

Triptorelin acetate

CAS140194-24-7

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.92

Dalareline

CAS52435-06-0

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.92

Alarelin

CAS79561-22-1

pharmaceutical raw material

ReferenceSame Category

Amsacrine

CAS51264-14-3

pharmaceutical raw material

ReferenceSame Category

Tizanidine

CAS51322-75-9

pharmaceutical raw material

ReferenceSame Category

Budesonide

CAS51333-22-3

pharmaceutical raw material

ReferenceSame Category

Fludrocortisone acetate

CAS514-36-3

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Health Hazard
Health Hazard
Danger
H360May damage fertility or the unborn child
Identifiers
IUPAC Name

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

InChIKey

SESQMDHICVIJCF-PCMWHEESSA-N

SMILES

C[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6

Synonyms (4)
  • (D-Ala(sup 6))-LHRH
  • (D-Ala6)-LHRH
  • 6-D-Ala-gonadorelin

Sourcing 6-D-Ala-gonadorelin?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→